🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

3 recruiting trials

for Multiple System Atrophy - Cerebellar Subtype (MSA-C)

The CurePSP Genetics Program NCT06647641n/a1 site📍 Boston Massachusetts General Hospital · Tests: Whole genome sequencing will be performed at the NIH The Study of Safety and Preliminary Efficacy of ALT001 in Patients With MultIple System Atrophy-Cerebellar Type NCT07514923EARLY Phase 12 sites📍 Beijing📍 Beijing yilong Wang · Tests: ALT001 Efficacy and Safety of Transcranial dIrect Current stiMulation in Multiple System Atrophy-Cerebellar Variant NCT06821256NA1 site📍 Salerno University of Salerno · Tests: Anodal transcranial direct current stimulation (a-tDCS), Sham stimulation
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy